The DES Center

Filter Your Results

 

News

 

Financing Will Support Orchestra BioMed's Product Pipeline Development

July 10, 2019 -- Orchestra BioMed, Inc. announced that financing will be used to accelerate and expand development of the company's lead and pipeline assets, including Bac…

DEBUT Trial Supports DCB-Only PCI in High-Bleeding-Risk Patients

June 26, 2019 -- Findings from the DEBUT trial were published by Tuomas T. Rissanen, MD, et al online ahead of print in The Lancet. DEBUT is a single-blind, randomized, noninf…

Orchestra BioMed Partners With Terumo to Develop and Commercialize the Virtue Sirolimus-Eluting Balloon

June 13, 2019 -- Orchestra BioMed, Inc. announced it has formed a global strategic partnership with Terumo Corporation for development and commercialization of Virtue sirolimu…

Findings Reported for FANTOM II Study of Reva Medical's Bioresorbable Scaffold

June 10, 2019 -- Twelve-month follow-up data from the FANTOM II study were published by Bernard Chevalier, MD, et al online in Circulation: Cardiovascular Interventions. …

Updated 1-Year BIOSOLVE-IV Data Presented for Biotronik's Magmaris Resorbable Scaffold

June 7, 2019 -- Biotronik announced that updated 12-month follow-up cohort results from the first 800 patients in the BIOSOLVE-IV registry were presented by the study's Pr…

Three-Year Data Presented for Subgroup Analysis of Small Vessels in Biotronik's BIO-RESORT Trial

May 21, 2019 -- Biotronik announced the presentation of 3-year outcomes in a subgroup of patients with small vessels in the BIO-RESORT randomized controlled trial by Principal…

Limitations in Identifying and Managing HBR Patients Undergoing PCI

Thomas Cuisset, MD

May/June 2019—A deficit of randomized PCI data including the high bleeding risk population makes it challenging to define the optimal management of these patients.

Key Factors for Clinical Decisions When Treating Patients at High Bleeding Risk

Michel Zeitouni, MD; and Gilles Montalescot, MD, PhD

May/June 2019—Less is more when treating high bleeding risk patients with latest-generation DESs and short DAPT duration.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.